Skip to content
OpenCapital
Get started

Science Applications International Corporation SAIC Restricted Cash Equivalents Current

Other financials

Income statement

See full
Revenue$1.9B+1.5%
Gross profit$249.0M+19.1%
Operating income$179.0M+47.9%
Net income$115.0M+69.1%
EPS (diluted)$2.61+83.8%

Balance sheet

See full
Cash & equivalents$117.0M+113%
Total debt$2.7B+9.6%
Total equity$1.4B-5.4%
Total assets$5.3B+2.4%

Cash flow

See full
Operating cash flow$127.0M+27.0%
CapEx$9.0M+12.5%
Free cash flow$118.0M+28.3%

Valuation

See full
Market cap$4.45B-27.6%

Profitability

See full
Gross margin12.5%+0.7pp
Operating margin7.9%+0.6pp
Net margin5.6%+0.9pp
FCF margin8.3%+2.2pp

Returns & leverage

See full
Return on equity27.7%+6.0pp
Debt / equity1.9×+0.3×
Current ratio1.2×+0.4×

Where this comes from

Reported directly by Science Applications International Corporation in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashEquivalentsCurrent.

The official record: Science Applications International Corporation’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Science Applications International Corporation's restricted cash equivalents current?
Science Applications International Corporation (SAIC) reported restricted cash equivalents current of $3M in Q1 2026.
How has Science Applications International Corporation's restricted cash equivalents current changed year-over-year?
Science Applications International Corporation's restricted cash equivalents current decreased by 0.0% year-over-year, from $3M to $3M.
What is the long-term trend for Science Applications International Corporation's restricted cash equivalents current?
Over 5 years (2021 to 2026), Science Applications International Corporation's restricted cash equivalents current has grown at a -9.7% compound annual growth rate (CAGR), from $5M to $3M.